Perioperative GLP1-RA management and risk of aspiration in patients with diabetes undergoing fast-track hip and knee arthroplasty Abstract INTRODUCTION
Lower Protein Diet Proven to Help Kidney Disease How might we cut the risk of dialysis and death in half
It offers multiple benefits such as strengthening the skin barrier, reducing inflammation, and improving uneven skin tone
April 1, 2025: MDL Against Ozempic and Other GLP-1s Top 1,600 in April As of April 1, 2025, there are 1,685 active lawsuits pending against Novo Nordisk and other pharmaceutical companies that sold GLP-1 drugs like Ozempic
Zepbound achieved massive commercial success in 2025, with estimated full-year sales reaching approximately $13.5 billion , representing a near-tripling (+175%) of revenue compared to the prior year